Skip to main content
Garni Barkhoudarian on Muck Rack

Garni Barkhoudarian

As seen in: Nature, Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Garni

Contact Garni, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Indications and outcomes of the extended endoscopic endonasal approach for the removal of "unconventional" suprasellar pituitary neuroendocrine tumors

|
By Domenico Solari, Elena d’Avella, Garni Barkhoudarian, Matteo Zoli
| thejns.org
Correspondence Elena d’Avella: Università degli Studi di Napoli "Federico II," Naples, Italy. elenadavella@gmail.com. INCLUDE WHEN CITING Published online March 28, 2025; DOI: 10.3171/2024.11.JNS242484. Disclosures Dr. Barkhoudarian reported consulting for Cerevasc Inc. and Medexus Inc. outside the submitted work. Dr. Kelly reported royalties from Mizuho, Inc. outside the submitted work.
Open in Who Shared Issue with article?

Enhanced recovery after brain tumor surgery: pilot protocol implementation in a large healthcare system

|
By Walavan Sivakumar, Jian Guan, Jean-Philippe Langevin, Garni Barkhoudarian
| thejns.org
Keywords: enhanced recovery after surgery; ERAS; craniotomy; brain surgery; neurosurgery; Value Oriented Architecture; cost per case Enhanced recovery after surgery (ERAS) protocols, first initiated as "fast-track surgery" by Professor Henrik Kehlet in the early 1990s,1 are multimodality care pathways designed to decrease the physiological stress of surgery, reduce complications, minimize postoperative debility, and accelerate recovery.
Open in Who Shared Issue with article?

An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma

|
By Garni Barkhoudarian, Sajeel Chowdhary, Michael Badruddoja, Nicholas Blondin
| Future Medicine Verified
CNS OncologyAhead of Print Short CommunicationOpen Access , , , , , , , , , , , , , & Abstract Aim: The EMulate Therapeutics Voyager™ is a simple, wearable, home-use device that uses an alternating electromagnetic field to alter biologic signaling within cells. Objective: To assess the safety/feasibility of the Voyager in the treatment of recurrent glioblastoma (rGBM).
Open in Who Shared Issue with article?
See all 4 articles